Clinical Trial Update: Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating linperlisib in combination with immunochemotherapy for relapsed/refractory large B-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• Linperlisib (linperlisib)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Relapsed/Refractory Large B-Cell Lymphoma | Phase 2 | Status: RECRUITING